Early research (Phase 1)Study completedNCT00390338What this trial is testingVaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) Pawel Kalinski 22
Early research (Phase 1)Study completedNCT00857025What this trial is testingBeta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forLung Cancer City of Hope Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT05017025What this trial is testingAurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung CancerWho this might be right forAdvanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more M.D. Anderson Cancer Center 32
Early research (Phase 1)Study completedNCT00019825What this trial is testingDecitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the PleuraWho this might be right forEsophageal CancerLung CancerMalignant Mesothelioma+1 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00436605What this trial is testingDasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV MelanomaWho this might be right forRecurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more National Cancer Institute (NCI) 39
Not applicableUnknownNCT01366183What this trial is testingChemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerWho this might be right forStage I Ovarian Cancer AJCC v6 and v7Stage IA Fallopian Tube Cancer AJCC v6 and v7Stage IB Fallopian Tube Cancer AJCC v6 and v7+13 more Gynecologic Oncology Group 290
Not applicableStudy completedNCT03776253What this trial is testingConquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic CancerWho this might be right forAdvanced Lung CarcinomaMalignant Female Reproductive System NeoplasmStage III Lung Cancer AJCC v8+4 more City of Hope Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT00376688What this trial is testingTemsirolimus in Treating Patients With Locally Advanced or Metastatic Breast CancerWho this might be right forRecurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7+3 more National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT00030407What this trial is testingCelecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung CancerWho this might be right forLung Cancer Barbara Ann Karmanos Cancer Institute 34
Not applicableUnknownNCT00463034What this trial is testingGenes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast CancerWho this might be right forBreast Cancer University of Sheffield 1,800
Testing effectiveness (Phase 2)Study completedNCT01126736What this trial is testingEribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Eisai Inc. 98
Testing effectiveness (Phase 2)Study completedNCT00982592What this trial is testingCombination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the StomachRecurrent Gastric Cancer+4 more National Cancer Institute (NCI) 124
Post-approval studies (Phase 4)Ended earlyNCT02467075What this trial is testingDouble-Blind Placebo-Controlled CIN TrialWho this might be right forAcute Kidney Injury University of Michigan 1
Testing effectiveness (Phase 2)Study completedNCT00077311What this trial is testingDocetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerWho this might be right forAnemiaDrug/Agent Toxicity by Tissue/OrganLung Cancer+1 more Alliance for Clinical Trials in Oncology 160
Testing effectiveness (Phase 2)Study completedNCT02108964What this trial is testingA Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid MalignanciesWho this might be right forAdvanced Non-small Cell Lung Cancer Novartis Pharmaceuticals 225
Testing effectiveness (Phase 2)Study completedNCT02860000What this trial is testingAlisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast CancerWho this might be right forEstrogen Receptor StatusHER2/Neu NegativeInvasive Breast Carcinoma+6 more Mayo Clinic 96
Large-scale testing (Phase 3)Study completedNCT02181998What this trial is testingA Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital SettingWho this might be right forMyocardial Infarction Boehringer Ingelheim 1,606
Large-scale testing (Phase 3)UnknownNCT00004209What this trial is testingCombination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerWho this might be right forLung Cancer Cancer Research UK
Testing effectiveness (Phase 2)UnknownNCT02631460What this trial is testingS1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLCWho this might be right forNSCLC Sun Yat-sen University 470
Early research (Phase 1)Active Not RecruitingNCT03907527What this trial is testingModified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal CancerWho this might be right forPlatinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+31 more Precigen, Inc 71